CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
about
shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapyThe PI3K/Akt Pathway in Tumors of Endocrine TissuesCancer Stem Cells and Their Interaction with the Tumor Microenvironment in NeuroblastomaNovel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaLung cancer stem cells and low-intensity laser irradiation: a potential future therapy?Notch signaling maintains neural rosette polarityCD133, Selectively Targeting the Root of CancerCD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheresThe endoplasmic reticulum-based acetyltransferases, ATase1 and ATase2, associate with the oligosaccharyltransferase to acetylate correctly folded polypeptidesG-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicProteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progressionOvarian cancer stem cell markers: prognostic and therapeutic implications.Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastomaA distinct gene expression signature characterizes human neuroblastoma cancer stem cells.Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiationCD133: a stem cell biomarker and beyondRole of stemness-related molecules in neuroblastoma.Molecular and genetic bases of neuroblastoma.Oncolytic viral therapy: targeting cancer stem cellsRegulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.Cell death, cavitation and spontaneous multi-differentiation of dental pulp stem cells-derived spheroids in vitro: a journey to survival and organogenesis.Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.A bispecific EpCAM/CD133-targeted toxin is effective against carcinomaAtypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines.Revealed: The spy who regulates neuroblastoma stem cells.Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristicsRUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.CD133 is essential for glioblastoma stem cell maintenance.Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma.CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.Sox2 maintains self renewal of tumor-initiating cells in osteosarcomasExpression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas.CFC1 is a cancer stemness-regulating factor in neuroblastoma.Editor's Highlight: Neonatal Activation of the Xenobiotic-Sensors PXR and CAR Results in Acute and Persistent Down-regulation of PPARα-Signaling in Mouse Liver.A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.Neuroblastoma stem cells and CFC1.
P2860
Q26765364-D704CFFF-A6F6-4A84-94E9-3CD0E7D7C7D9Q26770404-C886DC56-4CF8-4B83-9234-9955FA91828FQ26771238-4C01FBAB-27B8-4005-BFDB-C5A2C00080ABQ26777988-AEAC6AD4-D9D4-471B-AF20-52BBE6057026Q26822652-7A361BBA-902F-40E7-B5F8-26F3C3E5C2EAQ27021829-A6096FAD-E059-4B4B-8904-1F1DC880A6E3Q27321532-F17DC145-EC1D-4088-B10B-4EC112FB676EQ28066353-E600B982-5FDC-4611-AABF-715D7181F07AQ33908271-94EC2D65-CC97-4143-B3E3-0A0EEDA2C814Q34509754-539027B6-9AF1-4518-AB71-6B28159AEFD8Q34981973-F8330481-B096-4C9E-A0E0-CB64A8195702Q34999444-03872FD0-EBF5-44AF-833B-889884E75C64Q35606242-2FD192FF-9263-412E-8AAA-93E76D40154EQ35615455-909177AF-54B5-4921-97C7-4F68C8DFF314Q35952249-EE5B105A-C235-472E-8868-D2D57B4B09FEQ36148130-90210DCA-7B49-4393-8176-11BA7F1D6C60Q36664232-571D76B7-3D6A-44F7-9AD8-3F7F657CB030Q36982860-5D5CF8DD-4E78-4EA1-8481-395038AE9C17Q37995020-6F47A3F9-D110-4DE1-8219-4BCB69AC83AEQ38010376-5A3F8615-D3CF-4D70-91F0-173CDF3E52F1Q38212255-0B895A53-6766-4B2C-9FBD-DE1D06422CECQ38264665-15E17F08-09F6-4C23-B093-9A3982E02CBCQ38563194-40F4EC5D-B9A5-4983-90E6-C078A21235EAQ38801373-F8973273-B03B-401D-9828-1DA11839C48EQ38851381-F2322FEF-6F3E-4F57-8F44-2A792D3E18F3Q38867217-645C53C5-E0B6-418F-9239-6B37A6B30BB2Q38874577-FD75D87D-58C0-4914-96AE-D3B17780B3A5Q38931371-93D108E7-7A9B-4700-8B81-523A21793D9DQ39120248-02BEB2C5-EE71-4314-8E9F-EA06B9FEAAD0Q39126205-0F62ADA9-47D1-4FDF-9012-FBB8B47A14B1Q39212552-158638F2-57E4-4702-A9AC-26760504908CQ39362601-9FE11805-BBCA-4C52-B37C-5470CDFF14EBQ39384559-3AA5AABD-985B-42C9-AA87-84206DD404ADQ39465605-8FBC0F3A-BCCE-43C9-855E-CC0250D65520Q39472160-09B5E4CC-A75C-45D7-825E-F7F76B580C1FQ40695629-3D418CA2-94B8-43AB-A97D-5843FE2731B8Q41233127-DC40C693-8CAE-42C1-918F-E3E7CA8C5088Q41658107-6B86BFBD-F887-4DA3-9F18-8BF4F46B346DQ42269157-7EF2F313-21B9-49B7-BE96-D90EC0E08E98Q42341756-AF1D000B-7420-42F0-AB06-C78211CD92C4
P2860
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@en
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@nl
type
label
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@en
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@nl
prefLabel
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@en
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@nl
P2093
P2860
P356
P1433
P1476
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
@en
P2093
A Nakagawara
H Takenobu
O Shimozato
T Nakamura
Y Yamaguchi
P2860
P2888
P304
P356
10.1038/ONC.2010.383
P407
P577
2010-09-06T00:00:00Z